Company: PFSA
Filing Date: 2025-04-28
Form Type: S-4/A
Source: 0001213900-25-035718
Chunk: 7

Company: Profusa, Inc.
Filing Date: 2025-04-28
Form: S-4/A
Chunk 7
---
freeloans, including for funds deposited in the Trust Account in connection with extensions of the deadline by which NorthView had to consummate its initial business combination. These loans are due to be repaid at Closing, but are expected to be converted into shares of New Profusa Common Stock at a price of $2.22 per share. In connection with the Business Combination, the parties intend to consummate a financing, pursuant to which New Profusa would issue to certain investors the PIPE Convertible Notes (the “PIPE Subscription Agreement”). See section entitled “ Summary of The Proxy Statement/Prospectus — PIPE Transaction” for a summary of the terms of the PIPE agreement with the PIPE Investors. Compensation to be received by the Sponsor, its affiliates and promoters in connection with the Business Combination: The Sponsor beneficially owns 4,743,750 founder shares, and I -Bankersand Dawson James, the managing underwriters of NorthView’s IPO, together beneficially own 450,000 representative shares of NorthView Common Stock, which shares would become worthless if NorthView does not complete a business combination, as such NorthView Initial Stockholders have waived any right to redemption with respect to these shares. The Sponsor paid an aggregate of $25,000 for the 5,175,000 founder shares, 862,500 of which it subsequently forfeited for no consideration. Sponsor subsequently received an additional 431,250 founder shares through a 1.1 -for-1stock dividend. Such shares have an aggregate market value of approximately $57.4million based on the closing sale price of NorthView Common Stock of $12.10 on OTC Pink Sheets on April1, 2025. The Sponsor also beneficially owns 5,162,500 private placement warrants, for which it paid $5,162,500 and which will expire and be worthless if NorthView does not complete a business combination. In addition, as of the expected closing date of the Business Combination, the Sponsor will have lent to NorthView an estimated $1.9million pursuant to interest -freeloans, including for funds deposited in the Trust Account in connection with extensions of the deadline by which NorthView had to consummate its initial business combination. These loans are due to be repaid at Closing. These loans are due to be repaid at closing, but are expected to be converted into shares of New Profusa Common Stock at a price of $2.22 per share. This compensation will not result in a material dilution of the equity interests